
DORIAN Technologies is an innovative startup founded in 2020 in Genova, Italy, specializing in quantitative imaging and AI to optimize diagnosis, prognosis, and longitudinal monitoring of neurological diseases such as Alzheimer's and Parkinson's. The company offers advanced medical imaging analysis platforms like DOlab, which bridges research and clinical practice by providing automated, AI-powered quantification of imaging biomarkers. Their solutions include DOstat for customized data analytics and DOlearn for clinician training. DORIAN collaborates with hospitals and research institutions to develop biomarker-based diagnostic tools, enhancing diagnostic confidence and personalized healthcare. The company is a spin-off of INFN and has gained recognition through participation in European Angel Investment Summit and Unicredit StartLab.

DORIAN Technologies is an innovative startup founded in 2020 in Genova, Italy, specializing in quantitative imaging and AI to optimize diagnosis, prognosis, and longitudinal monitoring of neurological diseases such as Alzheimer's and Parkinson's. The company offers advanced medical imaging analysis platforms like DOlab, which bridges research and clinical practice by providing automated, AI-powered quantification of imaging biomarkers. Their solutions include DOstat for customized data analytics and DOlearn for clinician training. DORIAN collaborates with hospitals and research institutions to develop biomarker-based diagnostic tools, enhancing diagnostic confidence and personalized healthcare. The company is a spin-off of INFN and has gained recognition through participation in European Angel Investment Summit and Unicredit StartLab.